AIS Imaging is the first biotech firm to apply deep learning techniques to the application of hyperspectral imaging for the detection of Leukemia cells.
Our sensing technology employs a sophisticated deep learning system called convolution metabolite regression (CMR). This CMR system has been trained on a dataset of hyperspectral images to detect and quantify glucose and lactate concentrations at an accuracy comparable to conventional Raman spectroscopy.
Helicoid Project
Doctors can detect cancer cells
Happens on the spot while undergoing surgery
We are committed to creating a versatile ML model capable of integrating with hyperspectral imaging across multiple industries.
Biopharmaceutical
Environmental
Food Quality and Safety